⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMIX News
Autonomix Medical, Inc. Common Stock
Autonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy Delivery
globenewswire.com
AMIX
Autonomix Medical Enters into $4.9 Million Warrant Inducement Priced at a Premium to Market Under Nasdaq Rules
globenewswire.com
AMIX
Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission
globenewswire.com
AMIX
Autonomix Medical Congratulates Co-Founder & Chief Medical Officer Dr. Robert Schwartz on Receiving Prestigious 2026 Cardiovascular Tech Forum Lifetime Achievement Award
globenewswire.com
AMIX
Autonomix Medical Expands Precision Neuromodulation Platform with Broad New U.S. Patent Supporting Nerve Sensing, Mapping and Targeted Therapy
globenewswire.com
AMIX
Form 8-K
sec.gov
AMIX
Autonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical Study
globenewswire.com
AMIX
Autonomix Medical Secures New U.S. Patent Strengthening Next-Generation Precision Neuromodulation Platform
globenewswire.com
AMIX
Form 8-K
sec.gov
AMIX
Autonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform
globenewswire.com
AMIX